# Lorraine C. Racusen

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/lorraine-c-racusen/

## Facts

| Field | Value |
| --- | --- |
| Citations | 25,476 |
| Field | Renal Transplantation Outcomes and Treatments |
| h-index | 73 |
| i10-index | 150 |
| Last Known Institution | Johns Hopkins University |
| OpenAlex ID | https://openalex.org/A5109251304 |
| Works | 218 |

## Researcher papers

- [The Banff 97 working classification of renal allograft pathology](https://scholariq.org/papers/the-banff-97-working-classification-of-renal-allograft-pathology/)
- [Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions](https://scholariq.org/papers/banff-07-classification-of-renal-allograft-pathology-updates-and-future/)
- [International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology](https://scholariq.org/papers/international-standardization-of-criteria-for-the-histologic-diagnosis-of-renal/)
- [Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions](https://scholariq.org/papers/banff-2013-meeting-report-inclusion-of-c4d-negative-antibody-mediated-rejection/)
- [Antibody-Mediated Rejection Criteria - an Addition to the Banff ’97 Classification of Renal Allograft Rejection](https://scholariq.org/papers/antibody-mediated-rejection-criteria-an-addition-to-the-banff-97-classification/)
- [The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials](https://scholariq.org/papers/the-banff-2017-kidney-meeting-report-revised-diagnostic-criteria-for-chronic/)
- [The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody-mediated rejection](https://scholariq.org/papers/the-banff-2019-kidney-meeting-report-i-updates-on-and-clarification-of-criteria/)
- [The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology](https://scholariq.org/papers/the-banff-2015-kidney-meeting-report-current-challenges-in-rejection/)
- [Conversion From Calcineurin Inhibitors to Sirolimus Maintenance Therapy in Renal Allograft Recipients: 24-Month Efficacy and Safety Results From the CONVERT Trial](https://scholariq.org/papers/conversion-from-calcineurin-inhibitors-to-sirolimus-maintenance-therapy-in-renal/)
- [Mayo Clinic/Renal Pathology Society Consensus Report on Pathologic Classification, Diagnosis, and Reporting of GN](https://scholariq.org/papers/mayo-clinic-renal-pathology-society-consensus-report-on-pathologic/)

## Researcher topics

- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Organ Transplantation Techniques and Outcomes](https://scholariq.org/topics/organ-transplantation-techniques-and-outcomes/)
- [Renal and Vascular Pathologies](https://scholariq.org/topics/renal-and-vascular-pathologies/)
- [Acute Kidney Injury Research](https://scholariq.org/topics/acute-kidney-injury-research/)

## Researcher university

- [Johns Hopkins University](https://scholariq.org/institutions/johns-hopkins-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.